PSA response to secondary androgen deprivation following failed treatment of metastatic prostate cancer with the antiandrogen casodex.

Fabozzi, S J; Kolm, P; Schellhammer, P F.

Fabozzi SJ; Department of Urology and Office of Biostatistics, Center for Urological Oncology of Eastern Virginia Medical School, and Sentara Cancer Institute, Norfolk, Virginia, USA.

Urol Oncol ; 1(2): 64-6, 1995.

Article en En | MEDLINE | ID: mdl-21224093

Search on Google

Banco de datos: MEDLINE Idioma: En Año: 1995 Tipo del documento: Article

Banco de datos: MEDLINE Idioma: En Año: 1995 Tipo del documento: Article